These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 24945488)

  • 1. Left atrium function in patients with coronary artery disease.
    Facchini E; Degiovanni A; Marino PN
    Curr Opin Cardiol; 2014 Sep; 29(5):423-9. PubMed ID: 24945488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarction and atrial fibrillation: importance of atrial ischemia.
    Alasady M; Shipp NJ; Brooks AG; Lim HS; Lau DH; Barlow D; Kuklik P; Worthley MI; Roberts-Thomson KC; Saint DA; Abhayaratna W; Sanders P
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):738-45. PubMed ID: 23873140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the extent of coronary atherosclerotic disease on ST-segment changes induced by ST elevation myocardial infarction.
    Noriega FJ; Vives-Borrás M; Solé-González E; García-Picart J; Arzamendi D; Cinca J
    Am J Cardiol; 2014 Mar; 113(5):757-64. PubMed ID: 24406107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial infarction: a case report and review of the literature.
    Rose KL; Collins KA
    Am J Forensic Med Pathol; 2010 Mar; 31(1):1-3. PubMed ID: 19949318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac structure and function improvements in coronary artery disease combined with severe obstructive sleep apnea/hypopnea syndrome patients via noninvasive positive pressure ventilation therapy.
    Liu X; Feng L; Cao G; Huang H; Xu Q; Yu J; Zhang S; Zhou M
    Coron Artery Dis; 2014 Sep; 25(6):516-20. PubMed ID: 24870115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial natriuretic peptides: a new diagnostic tool for the internist].
    Boari B; Manfredini R; Fellin R
    Recenti Prog Med; 2005 Jun; 96(6):300-10. PubMed ID: 16078761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart.
    Maczewski M; Mackiewicz U
    Cardiovasc Pathol; 2007; 16(2):79-84. PubMed ID: 17317540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
    Tuñón J; Blanco-Colio L; Cristóbal C; Tarín N; Higueras J; Huelmos A; Alonso J; Egido J; Asensio D; Lorenzo Ó; Mahíllo-Fernández I; Rodríguez-Artalejo F; Farré J; Martín-Ventura JL; López-Bescós L
    Am J Cardiol; 2014 Feb; 113(3):434-40. PubMed ID: 24295549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced changes of B-type natriuretic peptide uncover the unknown coronary artery disease in patients with chest pain and normal left ventricular systolic function.
    Paraskevaidis IA; Tsougos E; Varounis C; Dagres N; Karatzas D; Parissis J; Kremastinos DT
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):72-8. PubMed ID: 20485180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
    Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of electrical cardioversion on left ventricular systolic function, left atrial size, ANP levels and enzymatic activity of CPK and CD-MB in serum of patients with paroxysmal atrial fibrillation].
    Spring A; Kosmala W; Mysiak A
    Przegl Lek; 1997; 54(9):585-90. PubMed ID: 9501676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.